About this trial
This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the Preparation Phase, we examined accessibility and feasibility of the treatment package.
In the current Optimization Phase, we will identify which components of treatment contribute to positive outcomes after acute hospitalization. We will carefully evaluate maintenance of remission, measured by rate of weight loss and end-of-trial status.
Eligibility criteria
Qualifiers
Diagnosis of Anorexia Nervosa at hospital admission
Medically Stable
Internet capability with videoconferencing
Weight restored (BMI > 19 kg/m2) at New York State Psychiatric Institute
Disqualifiers
Current substance use or other comorbid disorder requiring specialized treatment
Pregnancy
Imminent risk of suicide
Serious medical illness
Trial design
Treatments tested in this trial
- Relapse Prevention and Changing Habits (REACH+)
Treatment groups
26
Treatment groupsSee each treatment group below.
Sponsors and collaborators
New York State Psychiatric Institute
Lead sponsor
Columbia University
Collaborator
Brown University
Collaborator
National Institute of Mental Health (NIMH)
Collaborator